Innovative approach by Waymark enhances health outcomes for Medicaid patients

Waymark, a public benefit company dedicated to improving access and quality of care in Medicaid, today published a peer-reviewed study in the New England Journal of Medicine (NEJM) Catalyst evaluating the impact of its early intervention model in its first year of service.

Florida health officials provide scant details on measles cases, worrying health experts

On Sunday, public health officials in two Michigan counties warned their residents that they may have been exposed to measles. In Wayne County, an adult

March 6, 2024

Alopecia Areata Tied to Higher Risks of Autoimmune and Psychiatric Comorbidities

Patients with alopecia areata had a higher prevalence of autoimmune and psychiatric comorbidities at diagnosis and an increased risk of new onset of these comorbidities

August 1, 2024

Armed with Phase III win, Incyte eyes label expansion for Monjuvi

Incyte’s Monjuvi is approved by the US FDA as a second-line treatment of relapsed and refractory diffuse large B cell lymphoma (DLBCL) in combination with

August 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.